DTL recognized as liab or equity
An analyst is comparing a firm to its competitors. The firm has a deferred tax liability that results from MACRS for tax purposes. The firm is expected to continue to grow in the future. How should the liability be treated for analytical purposes?
A) Equity at full value
B) Liability at full value
C) PV should be treated as a liability with the remainder treated as equity
The answer is "A" and the reason given is that the DTL is not expected to reverse in the foreseeable future therefore the liability should be treated as equity in its full value.
My question is why would the company not be expected to be able to generate enough profit to cover the DTL? If the company is growing, that would suggest that in the future, they will make enough money to use the DTL which would mean it needs to be accounted for as a liability (bc cash payment for taxes in the future can be expected).
Any suggestions?? Thanks. |